{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T08:27:25Z","timestamp":1723278445938},"reference-count":56,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.2353\/ajpath.2009.090099","type":"journal-article","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T22:26:16Z","timestamp":1257459976000},"page":"2697-2708","source":"Crossref","is-referenced-by-count":16,"title":["TRAIL-Deficient Mice Exhibit Delayed Regression of Retinal Neovascularization"],"prefix":"10.1016","volume":"175","author":[{"given":"Kristin E.","family":"Hubert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Stempel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas S.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Powers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2009.090099_bib1","first-page":"576","article-title":"Variable oxygen exposure causes preretinal neovascularization in the newborn rat","volume":"34","author":"Penn","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.2353\/ajpath.2009.090099_bib2","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.2353\/ajpath.2009.090099_bib3","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.92.3.905","article-title":"Vascular endothelial growth factor\/vascular permeability factor expression in a mouse model of retinal neovascularization","volume":"92","author":"Pierce","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2009.090099_bib4","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1167\/iovs.03-0050","article-title":"Increased retinal neovascularization in Fas ligand-deficient mice","volume":"44","author":"Davies","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.2353\/ajpath.2009.090099_bib5","first-page":"532","article-title":"Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003. Anaheim, California)","volume":"12","author":"Lutty","year":"2006","journal-title":"Mol Vis"},{"key":"10.2353\/ajpath.2009.090099_bib6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0955-0674(99)80034-9","article-title":"Apoptosis control by death and decoy receptors","volume":"11","author":"Ashkenazi","year":"1999","journal-title":"Curr Opin Cell Biol"},{"key":"10.2353\/ajpath.2009.090099_bib7","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.ejca.2006.03.018","article-title":"The clinical trail of TRAIL","volume":"42","author":"Duiker","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.2353\/ajpath.2009.090099_bib8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nrd2637","article-title":"Directing cancer cells to self-destruct with pro-apoptotic receptor agonists","volume":"7","author":"Ashkenazi","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.2353\/ajpath.2009.090099_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1749-6632.2000.tb05598.x","article-title":"The complexity of TNF-related apoptosis-inducing ligand","volume":"926","author":"Abe","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.2353\/ajpath.2009.090099_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1359-6101(03)00029-7","article-title":"Apo2L\/TRAIL: apoptosis signaling, biology, and potential for cancer therapy","volume":"14","author":"Almasan","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.2353\/ajpath.2009.090099_bib11","first-page":"2770","article-title":"Molecular cloning and functional analysis of the mouse homologue of the KILLER\/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor","volume":"59","author":"Wu","year":"1999","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.090099_bib12","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1074\/jbc.M210783200","article-title":"Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)","volume":"278","author":"Schneider","year":"2003","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2009.090099_bib13","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1091\/mbc.E04-01-0059","article-title":"The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival","volume":"15","author":"Pritzker","year":"2004","journal-title":"Mol Biol Cell"},{"key":"10.2353\/ajpath.2009.090099_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cytogfr.2006.04.002","article-title":"The role of the TRAIL\/TRAIL receptors system in hematopoiesis and endothelial cell biology","volume":"17","author":"Zauli","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.2353\/ajpath.2009.090099_bib15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and characterization of a new member of the TNF family that induces apoptosis","volume":"3","author":"Wiley","year":"1995","journal-title":"Immunity"},{"key":"10.2353\/ajpath.2009.090099_bib16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1054\/drup.2001.0208","article-title":"Potential and caveats of TRAIL in cancer therapy","volume":"4","author":"Held","year":"2001","journal-title":"Drug Resist Updat"},{"key":"10.2353\/ajpath.2009.090099_bib17","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1128\/MCB.25.5.2000-2013.2005","article-title":"DR5 knockout mice are compromised in radiation-induced apoptosis","volume":"25","author":"Finnberg","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.2353\/ajpath.2009.090099_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jns.2006.08.018","article-title":"Death receptor expression and function at the human blood brain barrier","volume":"259","author":"Wosik","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.2353\/ajpath.2009.090099_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000086599","article-title":"TRAIL-induced apoptosis in human vascular endothelium is regulated by phosphatidylinositol 3-kinase\/Akt through the short form of cellular FLIP and Bcl-2","volume":"42","author":"Alladina","year":"2005","journal-title":"J Vasc Res"},{"key":"10.2353\/ajpath.2009.090099_bib20","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.4049\/jimmunol.171.3.1526","article-title":"TRAIL induces apoptosis and inflammatory gene expression in human endothelial cells","volume":"171","author":"Li","year":"2003","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2009.090099_bib21","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1080\/02713680500330355","article-title":"Altered retinal neovascularization in TNF receptor-deficient mice","volume":"30","author":"Ilg","year":"2005","journal-title":"Curr Eye Res"},{"key":"10.2353\/ajpath.2009.090099_bib22","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1167\/iovs.02-0478","article-title":"The role of Fas-FasL in the development and treatment of ischemic retinopathy","volume":"44","author":"Barreiro","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.2353\/ajpath.2009.090099_bib23","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1167\/iovs.06-0598","article-title":"Unique gene expression profiles of donor-matched human retinal and choroidal vascular endothelial cells","volume":"48","author":"Smith","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.2353\/ajpath.2009.090099_bib24","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/1521-4141(200208)32:8<2246::AID-IMMU2246>3.0.CO;2-6","article-title":"Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL\/Apo2L, using TRAIL\/Apo2L gene-deficient mice","volume":"32","author":"Sedger","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.2353\/ajpath.2009.090099_bib25","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1167\/iovs.05-1096","article-title":"T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification","volume":"47","author":"Banin","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.2353\/ajpath.2009.090099_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5517","article-title":"Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo","volume":"5","author":"Walczak","year":"1999","journal-title":"Nat Med"},{"key":"10.2353\/ajpath.2009.090099_bib27","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.1093\/emboj\/16.17.5386","article-title":"TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL","volume":"16","author":"Walczak","year":"1997","journal-title":"EMBO J"},{"key":"10.2353\/ajpath.2009.090099_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10456-007-9065-1","article-title":"Development of the retinal vasculature","volume":"10","author":"Fruttiger","year":"2007","journal-title":"Angiogenesis"},{"key":"10.2353\/ajpath.2009.090099_bib29","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.humpath.2005.07.019","article-title":"Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases","volume":"36","author":"Saitou","year":"2005","journal-title":"Hum Pathol"},{"key":"10.2353\/ajpath.2009.090099_bib30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1084\/jem.193.6.661","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis","volume":"193","author":"Smyth","year":"2001","journal-title":"J Exp Med"},{"key":"10.2353\/ajpath.2009.090099_bib31","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.4049\/jimmunol.169.9.4739","article-title":"TRAIL: a mechanism of tumor surveillance in an immune privileged site","volume":"169","author":"Lee","year":"2002","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2009.090099_bib32","first-page":"467","article-title":"Microglia and macrophages are increased in response to ischemia-induced retinopathy in the mouse retina","volume":"12","author":"Davies","year":"2006","journal-title":"Mol Vis"},{"key":"10.2353\/ajpath.2009.090099_bib33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1189\/jlb.0302117","article-title":"Role of MCP-1 and MIP-1alpha in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization","volume":"73","author":"Yoshida","year":"2003","journal-title":"J Leukoc Biol"},{"key":"10.2353\/ajpath.2009.090099_bib34","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1167\/iovs.07-1491","article-title":"MCP-1 deficiency delays regression of pathologic retinal neovascularization in a model of ischemic retinopathy","volume":"49","author":"Davies","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.2353\/ajpath.2009.090099_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.canlet.2008.02.003","article-title":"TRAIL and cancer therapy","volume":"263","author":"Kruyt","year":"2008","journal-title":"Cancer Lett"},{"key":"10.2353\/ajpath.2009.090099_bib36","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1084\/jem.189.8.1343","article-title":"Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine","volume":"189","author":"Griffith","year":"1999","journal-title":"TRAIL J Exp Med"},{"key":"10.2353\/ajpath.2009.090099_bib37","first-page":"17","article-title":"TNF-related apoptosis-inducing ligand (TRAIL) induces neuronal apoptosis in HIV-encephalopathy","volume":"50","author":"Miura","year":"2003","journal-title":"J Med Dent Sci"},{"key":"10.2353\/ajpath.2009.090099_bib38","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1084\/jem.20080201","article-title":"Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand","volume":"205","author":"Herold","year":"2008","journal-title":"J Exp Med"},{"key":"10.2353\/ajpath.2009.090099_bib39","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10495-009-0321-2","article-title":"Is TRAIL the holy grail of cancer therapy?","volume":"14","author":"Newsom-Davis","year":"2009","journal-title":"Apoptosis"},{"key":"10.2353\/ajpath.2009.090099_bib40","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/nm1627","article-title":"Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L\/TRAIL","volume":"13","author":"Wagner","year":"2007","journal-title":"Nat Med"},{"key":"10.2353\/ajpath.2009.090099_bib41","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/01.CIR.0000062702.60708.C4","article-title":"TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways","volume":"107","author":"Secchiero","year":"2003","journal-title":"Circulation"},{"key":"10.2353\/ajpath.2009.090099_bib42","doi-asserted-by":"crossref","first-page":"7888","DOI":"10.1158\/0008-5472.CAN-04-4278","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects","volume":"65","author":"Baader","year":"2005","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.090099_bib43","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1038\/sj.onc.1206520","article-title":"TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB","volume":"22","author":"Ehrhardt","year":"2003","journal-title":"Oncogene"},{"key":"10.2353\/ajpath.2009.090099_bib44","doi-asserted-by":"crossref","first-page":"15709","DOI":"10.1074\/jbc.M414469200","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase\/Akt","volume":"280","author":"Morel","year":"2005","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2009.090099_bib45","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.yexcr.2007.12.027","article-title":"Multiple effects of TRAIL in human carcinoma cells: induction of apoptosis, senescence, proliferation, and cytokine production","volume":"314","author":"Levina","year":"2008","journal-title":"Exp Cell Res"},{"key":"10.2353\/ajpath.2009.090099_bib46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ydbio.2004.12.017","article-title":"Attenuation of retinal vascular development and neovascularization during oxygen-induced ischemic retinopathy in Bcl-2\u2212\/\u2212 mice","volume":"279","author":"Wang","year":"2005","journal-title":"Dev Biol"},{"key":"10.2353\/ajpath.2009.090099_bib47","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1002\/dvdy.20837","article-title":"Attenuation of retinal vascular development and neovascularization in transgenic mice over-expressing thrombospondin-1 in the lens","volume":"235","author":"Wu","year":"2006","journal-title":"Dev Dyn"},{"key":"10.2353\/ajpath.2009.090099_bib48","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nm1095-1024","article-title":"Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity","volume":"1","author":"Alon","year":"1995","journal-title":"Nat Med"},{"key":"10.2353\/ajpath.2009.090099_bib49","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1549-8719.2000.tb00131.x","article-title":"Roles of endothelial cell migration and apoptosis in vascular remodeling during development of the central nervous system","volume":"7","author":"Hughes","year":"2000","journal-title":"Microcirculation"},{"key":"10.2353\/ajpath.2009.090099_bib50","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nm877","article-title":"Leukocytes mediate retinal vascular remodeling during development and vaso-obliteration in disease","volume":"9","author":"Ishida","year":"2003","journal-title":"Nat Med"},{"key":"10.2353\/ajpath.2009.090099_bib51","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nm0104-12","article-title":"FasL, leukocytes and vascular modeling","volume":"10","author":"Ferguson","year":"2004","journal-title":"Nat Med"},{"key":"10.2353\/ajpath.2009.090099_bib52","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/dvdy.10412","article-title":"Thrombospondin-1-deficient mice exhibit increased vascular density during retinal vascular development and are less sensitive to hyperoxia-mediated vessel obliteration","volume":"228","author":"Wang","year":"2003","journal-title":"Dev Dyn"},{"key":"10.2353\/ajpath.2009.090099_bib53","doi-asserted-by":"crossref","first-page":"13313","DOI":"10.1074\/jbc.273.21.13313","article-title":"Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells","volume":"273","author":"Gerber","year":"1998","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2009.090099_bib54","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0002-9440(10)65284-4","article-title":"Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression","volume":"154","author":"Nor","year":"1999","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2009.090099_bib55","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1126\/science.286.5445.1735","article-title":"Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity","volume":"286","author":"Bouillet","year":"1999","journal-title":"Science"},{"key":"10.2353\/ajpath.2009.090099_bib56","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2004.12.030","article-title":"Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function","volume":"17","author":"Chen","year":"2005","journal-title":"Mol Cell"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010607778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010607778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T13:24:50Z","timestamp":1558617890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010607778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0002944010607778"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2009.090099","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}